findmyKOL

Antonio Guasch, MD

Basic profile

Emory University

ORCIDNone on fileNPI
RegionAtlanta, GA · SoutheastSpecialtyNephrologyFocusNephrology
Last active 2010findmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publicationSee ScholarshipOnline presenceNot yet checkedPaymentsNone reportedNIH funding1997–2010Why? →

Antonio Guasch is a Nephrology physician affiliated with Emory University. OpenAlex indexes 36 publications with 3,201 citations (h-index 20); ClinicalTrials.gov lists 2 registered studies matched to this name.

Overview

Scholarship

indexed output and impact (OpenAlex)
36publications

Distinct works indexed by OpenAlex.

3,201citations

Total citations across indexed works.

20h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
2clinical trials

Investigator role on registered studies.

View trials
4NIH grants · 1997–2010

Federally funded research awards.

View funding

Clinical trials

Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.

Medicare prescribing footprint (2023)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    52.1%
    Statin13.9%
    Atorvastatin Calcium70%Rosuvastatin Calcium17%Pravastatin Sodium9%Simvastatin5%
    Part D<11 patients
    Beta blocker13.7%
    Carvedilol36%Metoprolol Tartrate34%Metoprolol Succinate26%Labetalol Hcl5%
    Part D<11 patients

    + 6 more classes in this area

  • Metabolism & gastrointestinal

    27.8%
    Corticosteroid15.2%
    Prednisone100%
    Part D67 patients
    Proton pump inhibitor6%
    Pantoprazole Sodium64%Omeprazole24%Esomeprazole Magnesium12%
    Part D<11 patients

    + 4 more classes in this area

  • Hormonal (systemic)

    6.9%
    Calcium-sensing Receptor Agonist5.5%
    Cinacalcet Hcl100%
    Part D17 patients
    Mineralocorticoids0.8%
    Fludrocortisone Acetate100%
    Part D<11 patients

    + 1 more class in this area

Where care is delivered (Part B)92.2% facility · 7.8% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

4 NIH research awards on record, funded 19972010 per NIH RePORTER. The latest:

Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”